Showing results (351-360 of 388) with videos related to
Sort By:
Pageof 39
The Lancet. Oncology|August 14, 2018
Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour GroupStefan Rutkowski, Piergiorgio Modena, Daniel Williamson, et al.The Lancet. Oncology|August 29, 2014
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trialRoger Stupp, Monika E Hegi, Thierry Gorlia, et al.Acta Neuropathologica|February 14, 2019
Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCAYanghao Hou, Jorge Pinheiro, Felix Sahm, et al.Advances in Radiation Oncology|December 11, 2020
Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 TrialStefan Dietzsch, Felix Placzek, Klaus Pietschmann, et al.Brain Pathology (Zurich, Switzerland)|September 25, 2018
Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological featuresFelipe Andreiuolo, Pascale Varlet, Arnault Tauziède-Espariat, et al.European Journal of Cancer (Oxford, England : 1990)|April 26, 2019
Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experienceElke Pfaff, Ahmed El Damaty, Gnana Prakash Balasubramanian, et al.Acta Neuropathologica|February 2, 2025
MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade gliomaLea L Friker, Thomas Perwein, Andreas Waha, et al.Nature|May 23, 2014
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencingVolker Hovestadt, David T W Jones, Simone Picelli, et al.Lancet (London, England)|February 21, 2019
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trialUlrich Herrlinger, Theophilos Tzaridis, Frederic Mack, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation CohortMartin Mynarek, Katja von Hoff, Torsten Pietsch, et al.Pageof 39